About this trial
Colorectal cancer is a major cause of cancer-related morbidity and mortality worldwide, and early detection significantly improves patient outcomes. The fecal immunochemical test (FIT) is a non-invasive stool-based test used for detection of colorectal cancer; however, its diagnostic performance varies according to lesion type and anatomical location.
This prospective observational cohort study aims to evaluate the diagnostic accuracy of quantitative fecal immunochemical testing (qFIT) in detecting colorectal cancer and precancerous lesions, including advanced adenomas and sessile serrated lesions, in adults undergoing colonoscopy in Sohag Government. The study will assess the sensitivity, specificity, and optimal cutoff values of qFIT according to lesion type, location, and histopathological characteristics.
Eligibility criteria
Qualifiers
Adults aged 40 to 75 years
Individuals undergoing screening or diagnostic colonoscopy
Participants able to provide informed consent
Disqualifiers
Age below 40 years or above 75 years
History of colorectal surgery
Inflammatory bowel disease
Inadequate bowel preparation
Trial design
Treatments tested in this trial
- Not listed